Evaluation of expression pattern of selected genes associated with IL12/23 signaling paths in psoriatic patients during cyclosporine A therapy

Multi-omics integration reveals molecular networks and regulators of psoriasis

(2019) Yuqi Zhao et al.   BMC Systems Biology

Effects of Cyclosporine on Palmoplantar Pustulosis and Serum Expression of IL-17, IL-23, and TNF-α

(2019) Xian-Hua Jin et al.   Dermatology and Therapy

Risk Factors Affecting Adverse Effects of Cyclosporine A in a Real-World Psoriasis Treatment

(2018) Bo Ri Kim et al.   Annals of Dermatology

More Than a Decade of Molecular Diagnostic Cytopathology Leading Diagnostic and Therapeutic Decision-Making

(2018) Manuel Salto-Tellez   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Molecular imaging and molecular diagnostics: two sides of the same coin?

(2018) Marcus Hacker et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders

(2018) M.J. Gooderham et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Variances in the mRNA expression profile of TGFβ1-3 isoforms and its TGFΒRI-III receptors during treatment of psoriatic patients with cyclosporin A

(2018) Anna Michalska-Bańkowska et al.   Postepy Dermatologii i Alergologii

A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage

(2018) Vu L. Ngo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis

(2018) Curdin Conrad et al.   Nature Communications

Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis

(2018) Aditi Chandra et al.   Clinical Epigenetics

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice

(2018) Nevena Skroza et al.   Therapeutics and Clinical Risk Management

Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon

(2018) Alessio Mylonas et al.   Frontiers in Immunology

Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience

(2017) Gabrielle Brown et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis

(2017) G. Girolomoni et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The role of IL-12/23 in T cell–related chronic inflammation: implications of immunodeficiency and therapeutic blockade

(2017) Anna Schurich et al.   RHEUMATOLOGY

IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis

(2017) Nehal N. Mehta et al.   Scientific Reports

Expression of sirtuins 1, 6, tumor necrosis factor, and interferon-γ in psoriatic patients

(2016) H Rasheed et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine

(2015) R Kaddurah-Daouk et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

(2015) Christophe Le Tourneau et al.   JNCI-Journal of the National Cancer Institute

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

(2015) Christophe Le Tourneau et al.   JNCI-Journal of the National Cancer Institute

A Single Intradermal Injection of IFN-γ Induces an Inflammatory State in Both Non-Lesional Psoriatic and Healthy Skin

(2012) Leanne M. Johnson-Huang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response

(2010) Alexander Panda et al.   JOURNAL OF IMMUNOLOGY

Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments

(2009) J. Seneschal et al.   BRITISH JOURNAL OF DERMATOLOGY